High-purity Alzheimer’s peptides empower laboratories globally through rPeptide delivering abeta 1-40 for aggregation, toxicity, and therapeutic discovery studies requiring reliable, reproducible experimental outcomes for advanced neuroscience.
High-purity Alzheimer’s peptides empower laboratories globally through rPeptide delivering abeta 1-40 for aggregation, toxicity, and therapeutic discovery studies requiring reliable, reproducible experimental outcomes for advanced neuroscience.